Back

Diflunisal therapy in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis

30 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Cardiac amyloidosis (2) Treatment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr David Abraham

Manaus (Brazil)

9 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor A. Sakalidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Doctor N. Mora Ayestaran (Pamplona, Navarra, ES)
Abstract Slides Video
Presentation thumbnail
Professor J. Smith (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Doctor L. Hauptmann (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Cardiac amyloidosis (2)

The Event

Event poster

ESC Congress 2025

30 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
New horizons in transthyretin cardiac amyloidosis therapy: A systematic review and meta-analysis of sodium-glucose cotransporter 2 inhibitors efficacy
31 August 2025
thumbnail
Congress Presentation
Redefining the epidemiology of cardiac amyloidosis. A systematic review of screening studies
21 May 2022
thumbnail
Congress Presentation
Effect of acoramidis on all-cause mortality, cardiovascular hospitalization and NT-proBNP in variant ATTR-CM - results from ATTRibute-CM
18 May 2025
thumbnail
Congress Presentation
Stabilizers of transthyretin in amyloid cardiomyopathy: a systematic review and meta-analysis.
11 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources